Vice President, Integrated Drug & Tech Discovery, Interventional Oncology

Johnson & Johnson•Boston, MA

39d•$218,000 - $401,350

About The Position

Johnson & Johnson Innovative Medicine is currently seeking a Vice President, Integrated Drug & Tech Discovery to join our Interventional Oncology (INTO) team in North America (Spring House, PA; Raritan, New Jersey; or Boston, MA). Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Our Oncology team is focused on the elimination of cancer by discovering new pathways and modalities to finding treatments and cures. We lead where medicine is going and need innovators with an unwavering commitment to results. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at https://www.jnj.com/innovative-medicine The Vice President of Integrated Drug and Tech Discovery for Interventional Oncology (INTO) will be accountable for designing and executing a cross-disciplinary scientific strategy that integrates pharmaceutical discovery, translational research, and MedTech innovation to advance breakthrough intratumorally-delivered drugs and associated procedures. This leader will operate at the forefront of oncology research, integrating advances in drug discovery and development, biomarkers and diagnostics, procedural technologies and workflows, and data-driven tools to create new paradigms for patient care in Interventional Oncology. The successful candidate will bring deep experience in oncology drug discovery and development, with a strong preference for expertise in Interventional Oncology, coupled with the ability to lead diverse teams spanning Pharma and MedTech disciplines. This role requires not only scientific depth, but also an entrepreneurial, adaptive leadership approach to drive innovation at the intersection of fields.

Requirements

PhD, MD, or MD/PhD with 12–15+ years of experience in oncology drug discovery, translational research, and/or clinical development is required.
Demonstrated ability to advance molecules and/or interventional technologies from pre-clinical discovery through early-stage clinical development is required; experience developing procedural strategies strongly preferred.
Strong leadership record in managing multidisciplinary teams across Pharma with success in both direct line management and global matrix leadership is required.
Track record of collaborating across functions (scientific, engineering, regulatory, commercial) and fostering a culture of innovation is required.
Entrepreneurial mindset with the ability to adapt strategy and execution in the face of uncertainty and rapidly evolving science is required.
Demonstrated abilities with exceptional communication skills to bridge diverse stakeholders—from scientists and engineers to clinicians, regulators, and executives is required.

Nice To Haves

Experience in Interventional Oncology and/or MedTech is strongly preferred.
Similar leadership experience in MedTech is preferred.

Responsibilities

Strategic Leadership: Define and implement a global research agenda that advances innovation in Interventional Oncology, integrating pharmaceutical and MedTech capabilities into cohesive strategies
Portfolio Development: Lead a team advancing a portfolio of interventional and immuno-oncology assets into the clinic, with accountability for target identification, validation, and translation
Device, Procedure, and Biomarker Integration: Drive the design and implementation of device, procedure, and biomarker strategies that support successful solutions
Cross-Sector Team Leadership: Build, inspire, and direct high-performing teams across Pharma and MedTech, ensuring collaboration across scientific, clinical, engineering, and business functions
External Innovation: Partner with External Innovation, Business Development, and global innovation networks to evaluate and integrate external opportunities in both Pharma and MedTech domains
Collaboration with Leadership & Stakeholders: Align with senior leadership across Oncology, MedTech, and Global R&D, while also engaging investigators, KOLs, and advisory boards to shape and execute strategy.
Entrepreneurial Execution: Apply an agile, entrepreneurial approach to navigate scientific, regulatory, and organizational uncertainty, ensuring delivery against strategic priorities.

Benefits

medical, dental, vision, life insurance, short- and long-term disability, business accident insurance, and group legal insurance.
Company’s consolidated retirement plan (pension) and savings plan (401(k)).
Company’s long-term incentive program.
Vacation –120 hours per calendar year
Sick time - 40 hours per calendar year; for employees who reside in the State of Washington –56 hours per calendar year
Holiday pay, including Floating Holidays –13 days per calendar year
Work, Personal and Family Time - up to 40 hours per calendar year
Parental Leave – 480 hours within one year of the birth/adoption/foster care of a child
Condolence Leave – 30 days for an immediate family member: 5 days for an extended family member
Caregiver Leave – 10 days
Volunteer Leave – 4 days
Military Spouse Time-Off – 80 hours